Big Rock Partners Acquisition Corp. (BRPA) Completes NeuroRx Deal

Big Rock Partners Acquisition Corp. (BRPA) Completes NeuroRx Deal

Big Rock Partners Acquisition Corp. (NASDAQ:BRPA) announced that it has completed its business combination with with drug developer NeuroRx. The combined company will now be renamed NRx Pharmaceuticals and will begin trading shortly on the Nasdaq under the ticker symbol “NRXP”. This marks the end of a long journey for Big Rock, which began its
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.